Which companies produce and supply donepezil hydrochloride internationally?
Donepezil hydrochloride, marketed primarily under the brand name Aricept, is a cholinesterase inhibitor used to treat Alzheimer's disease. Multiple suppliers offer bulk active pharmaceutical ingredients (APIs), intermediate commodities, or finished dosage forms.
Major API Suppliers of Donepezil Hydrochloride
1. Jiangsu Hengrui Medicine Co., Ltd.
Location: China
Product: Fully compliant with international standards, including USP and EP
Capacity: Estimated at hundreds of kilograms annually
Certifications: GMP, ISO 9001
2. Zhejiang Xianju Pharmaceutical Co., Ltd.
Location: China
Product: USP-grade donepezil hydrochloride
Certifications: GMP, ISO 9001
3. Shanghai Synthealth Pharmaceuticals
Location: China
Product: Generic APIs including donepezil hydrochloride
Status: Active on the Asian market
4. Jinan Zhongwei Pharmaceutical Co., Ltd.
Location: China
Product: GMP-certified API production
Capacity & Certification: Details undisclosed but compliant with international standards
5. Hubei Haodong Pharmaceutical Co., Ltd.
Location: China
Product: Donepezil hydrochloride for bulk supply
Certifications: GMP
Additional Suppliers and Synthetic Intermediates
Many Chinese API manufacturers produce donepezil hydrochloride for export.
European and Indian suppliers also manufacture intermediates used in synthesis but less often the final API.
Finished Dosage Form Manufacturers
Several pharmaceutical companies globally produce donepezil in finished dosage forms, either under proprietary or generic labels.
Notable companies include Mylan (now part of Viatris), Teva, and Sandoz.
Global Distribution & Market
Region
Main Suppliers
Estimated Market Share
Regulatory Certifications
China
Jiangsu Hengrui, Zhejiang Xianju
70%
GMP, ISO 9001
India
Sun Pharma, Cadila Healthcare
20%
WHO-GMP, DGCI approval
Europe/US
Mylan, Teva, Sandoz
10%
FDA, EMA approvals
Regulatory and Quality Considerations
Most API suppliers in China hold GMP certificates recognized by the Chinese authority (CFDA).
Exported APIs targeting North American and European markets require compliance with US FDA or EMA regulations.
Quality standards include USP, EP, or JP monographs.
Supply Chain and Sourcing Risks
Chinese suppliers dominate the API market, introducing risks related to regulatory changes and trade policies.
Indian and European sources provide alternatives but at different scales and certification standards.
Lead times for API production range from 4 to 12 weeks, depending on order size and certification compliance.
Summary
Most donepezil hydrochloride APIs originate from China, with a smaller but significant presence in India and Europe. Certified suppliers adhere to international GMP standards, essential for export and pharmaceutical manufacturing.
Key Takeaways
China supplies approximately 70% of global donepezil hydrochloride APIs, with major manufacturers including Jiangsu Hengrui and Zhejiang Xianju.
GMP certification and regulatory compliance are critical for international supply acceptance.
Supply stability depends on geopolitical factors, trade agreements, and regulatory oversight.
Many alternatives exist in India and Europe, offering diversified sourcing options.
Finished dosage forms are produced by several multinational pharmaceutical companies, with leading providers including Mylan, Teva, and Sandoz.
FAQs
Are there non-Chinese suppliers of donepezil hydrochloride?
Yes, suppliers in India and Europe produce APIs, but their market share is smaller, and regulatory recognition varies.
What certifications should suppliers have for international distribution?
GMP certification recognized by local authorities (FDA, EMA, CFDA) is essential alongside compliance with USP or EP standards.
What is the typical lead time for API orders?
Lead times range from 4 to 12 weeks based on supplier capacity, order size, and certification process.
Can I source completed pharmaceutical products instead of APIs?
Yes, several multinational firms produce finished donepezil hydrochloride tablets, which are available globally.
How do I assess API quality from suppliers?
Review certification records, batch testing reports, and perform third-party testing if necessary, ensuring compliance with regulatory standards.
References
[1] Chinese Pharmacopoeia. (2020). "Donepezil Hydrochloride." 12th Edition.
[2] US Food and Drug Administration. (2022). "API GMP Inspections."
[3] European Medicines Agency. (2022). "Quality standards for Active Ingredients."
[4] MarketWatch. (2023). "Global Donepezil Hydrochloride Market Analysis."
[5] IQVIA. (2022). "Active Pharmaceutical Ingredient Market Reports."
